July 27, 2026

Gerresheimer Opens New Pharmaceutical Glass Packaging Plant in China

Pharma

Gerresheimer, a German company specializing in glass, specialty glass, and plastic packaging for the pharmaceutical, cosmetic, and food industries, announced the commissioning of a new plant in Zhenjiang, China, for the production of primary pharmaceutical glass containers and packaging.

After approximately four years of construction, a modern, energy-efficient building has been erected on an area of ​​approximately 40,000 square meters in the Zhenjiang Economic Development Zone in Jiangsu Province. The facility fully complies with the strict regulatory requirements of the pharmaceutical and biotechnology industries. An additional space of over 33,000 square meters is available for future expansion. The new plant also sets standards in sustainability.

With this new construction, Gerresheimer is doubling its production capacity for primary packaging for injectables in China. Gerresheimer currently employs approximately 250 people at the facility, producing pharmaceutical vials and ampoules, primarily for the Chinese market. Approximately 50 new jobs are expected to be created in the coming years. By opening its fourth tubular glass plant in China, Gerresheimer continues its successful 20-year partnership with Shuangfeng Glass.

The new plant in Zhenjiang is equipped with state-of-the-art glass molding equipment, as well as intelligent, highly automated production and logistics systems. Borosilicate glass vials and ampoules are produced in a wide range of sizes and designs in accordance with Chinese Good Manufacturing Practice (GMP) standards for pharmaceutical packaging. Controlled areas include over 2,700 m² of ISO Class 8 cleanrooms, an ISO Class 7 microbiology laboratory, and over 700 m² of ISO Class 8 ampoule and vial siliconization space. The plant also utilizes a comprehensive ISO-certified quality and environmental management system.

The plant was designed and built in accordance with Chinese "green factory" principles and the U.S. Green Building Council's LEED Gold certification standards. A 2 MW rooftop photovoltaic system generates clean electricity that is used directly in the plant. Water, including rainwater and condensate from air conditioning systems, is continuously collected and recycled as a valuable resource. Heat generated during the production process is used to heat other areas. This energy and resource efficiency of the new plant, along with the use of electricity from renewable sources, makes a positive contribution to the Gerresheimer Group's sustainability goals.

 

Source: UNIPACK.RU

 

Latest posts by email:
To subscribe to the newsletter, first Come in Either Register

Other news

Pharma

In today’s world, effective resource management is becoming an increasingly crucial aspect of successful business operations. This is especially true for industries where equipment plays a key role—such as pharmaceuticals, cosmetology, and the food industry.

02.10.2025
Pharma

The Russian pharmaceutical manufacturer PFK "Renewal", operating under the Renewal brand, has commissioned a new production facility for the production of vital and essential medicines (VED) in the Novosibirsk region. The area of the complex exceeds 18.1 thousand square meters, and the design capacity reaches 100 million packages of finished products annually.

23.09.2026
Pharma

"VERTEX" is completing the commissioning of a blister-cardboard line with double-sided aluminum packaging, unique for its capacities. The new machine will become the tenth blister line of the enterprise and will allow to produce about 260 thousand packages by the end of 2026.

21.09.2026
Pharma

""""On Moscow Industry Day, Sergei Sobyanin opened a new production complex "Generium-Next" (GC "Farmstandart") at the Alabushevo site. The company will produce genetically engineered drugs for orphan and socially significant diseases for 8.5 billion rubles.

18.09.2026
Pharma

""PSK Pharma" company has completed a major project to modernize the production site of capsules with powder for inhalation at its own enterprise in the "Dubna" special economic zone. Investments exceeded 1 billion rubles, which made it possible to double the capacity of the line — from 80 to 160 thousand capsules per hour — and purchase new analytical and tablet equipment.

17.09.2026
Pharma

PJSC "Biosynthesis", one of the largest pharmaceutical enterprises in the Penza region, is preparing to launch a reconstructed production site for tablet dosage forms. The volume of investments in the project is 350 million rubles, and the implementation will increase the production of drugs, including those included in the list of VED.

16.09.2026
Pharma

Pharmaceutical manufacturer "Nizhpharm" announced the launch of a new line of packaging and packaging of soft dosage forms. The volume of investments in the project amounted to 158 million rubles, the maximum speed of the equipment reaches 270 packages per minute, which will increase production by 50%.

15.09.2026
PharmaTECH Kazakhstan 2026
Pharma

The PharmaTECH Kazakhstan exhibition, "Equipment, Raw Materials, and Technologies for the Pharmaceutical Industry," will take place from May 20 to 22, 2026, in Almaty.

21.05.2026
Pharma

A new production complex for manufacturing pharmaceuticals and cosmetics may be established in the "Innopolis" Special Economic Zone.

13.05.2026
Pharma

The Board of the Eurasian Economic Commission (EEC) has approved a draft amendment to the GMP Rules, revising the requirements for the manufacture of sterile medicinal products. The document introduces stricter monitoring protocols for cleanrooms and personnel operations.

20.04.2026
Pharma

LLC LeanGroup-Ural, a manufacturer of tubes for cosmetic, pharmaceutical, and food products, participated in the industry forum organized by the Russian Perfume and Cosmetics Association titled "Sensorics in Cosmetics."

15.04.2026
Pharma

On March 16–17, 2026, an India-Russia pharmaceutical industry meeting is taking place in Moscow. The event is organized by the Pharmaceutical Export Promotion Council of India (Pharmexcil).

17.03.2026